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Abstract
Parkinson’s disease (PD) is the most prevalent neurodegenerative motor disorder worldwide, and
results in the progressive loss of dopamine (DA) neurons in the substantia nigra pars compacta.
Gene-environment interactions are believed to play a significant role in the vast majority of PD
cases, yet the toxicants and the associated genes involved in the neuropathology are largely ill-
defined. Recent epidemiological and biochemical evidence suggests that methylmercury (MeHg)
may be an environmental toxicant that contributes to the development of PD. Here we report that a
gene coding for the putative multidrug resistance protein MRP-7 in Caenorhabditis elegans (C.
elegans) modulates whole animal and DA neuron sensitivity to MeHg. In this study we
demonstrate that genetic knockdown of MRP-7 results in a 2-fold increase in Hg levels and a
dramatic increase in stress response proteins associated with the endoplasmic reticulum, golgi
apparatus, and mitochondria, as well as an increase in MeHg-associated animal death. Chronic
exposure to low concentrations of MeHg induces MRP-7 gene expression, while exposures in
MRP-7 genetic knockdown animals results in a loss of DA neuron integrity without affecting
whole animal viability. Furthermore, transgenic animals expressing a fluorescent reporter behind
the endogenous MRP-7 promoter indicate that the transporter is expressed in DA neurons. These
studies show for the first time that a multidrug resistance protein is expressed in DA neurons, and
its expression inhibits MeHg-associated DA neuron pathology.
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Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative disease that is characterized by
the selective loss of dopamine (DA) neurons in the substantia nigra (Martin et al. 2011, Nass
& Przedborski 2008). Hallmark symptoms of the disorder include resting tremors,
bradykinesia, and muscle rigidity. The rare familial forms of PD have provided significant
insight into possible molecular pathways involved in the more common idiopathic PD (IPD),
and include those involved in mitochondrial function and regulating oxidative stress (Nass
& Przedborski 2008). Although the etiology of IPD is largely unknown, it is likely that
environmental components contribute significantly to the development of the disorder.
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Methylmercury (MeHg) is a ubiquitous environmental toxicant that primarily targets the
central nervous system (Clarkson & Magos 2006). Exposure to high levels of MeHg can
result in motor and sensory deficits, mental retardation, and death. MeHg can diffuse
relatively easily through cellular membranes, and the toxicant has been shown to disrupt a
number of metabolic processes including respiration, calcium homeostasis, and redox
balance (Atchison & Hare 1994, Rush et al. 2012). The toxicant has also been shown to
induce the expression of glutathione S-transferases (GSTs) that conjugate xenobiotics to
reduced glutathione (GSH) that are then exported from the cell (Di Simplicio et al. 1993, Yu
et al. 2010). DA neurotransmission is also sensitive to MeHg as the toxicant can cause
abnormal DA release, reuptake, and metabolism (Faro et al. 2002, Dreiem et al. 2009).
MeHg has been shown to accumulate in the substantia nigra and striatum during chronic
exposure through drinking water, and although the molecular mechanisms are not known,
recent studies suggest that the toxicant may also contribute to the development of PD
(Petersen et al. 2008, Moller-Madsen 1994).
Multidrug resistance proteins (MRPs) are a subset of the ATP-binding cassette genes that
are phase III detoxification proteins involved in transporting exogenous and endogenous
compounds across cellular membranes. The proteins typically have two nucleotide binding
domains, and hydrolyze ATP to pump the substrates against a concentration gradient (Borst
et al. 2000, Chen & Tiwari 2011). The nine MRP proteins found in vertebrates, categorized
based on membrane topography, tissue distribution, and substrate specificity, have been
extensively characterized in non-CNS tissues including the kidney, intestine, muscle, and
skin (Borst et al. 2000, Chen & Tiwari 2011, Dean et al. 2001). The expression and function
of MRPs in normal brain physiology have been contradictory and controversial, largely due
to low expression levels that may be altered in vitro and interfering interactions with other
biomolecules (Dallas et al. 2006). However, there is evidence that MRPs are expressed in
neurons, likely play a role in modulating redox homeostasis and GSH efflux, and may
contribute to the development of neurodegenerative diseases (Dallas et al. 2006, Furuno et
al. 2002, Lam et al. 2001). Although MRPs have not been directly associated with the
development of PD, transporter polymorphisms, both alone and in concert with pesticide
exposures, have been correlated with an increased propensity to develop the disease (Lee et
al. 2004, Dutheil et al. 2010). MRPs have not been shown to be expressed in DA neurons in
humans or other mammalian systems, but they are known to transport MeHg conjugates out
of cells and increase excretion in the kidney and liver (Madejczyk et al. 2007, Zalups &
Bridges 2009).
The nematode Caenorhabditis elegans (C. elegans) is a useful genetic model to dissect the
molecular components involved in DA neuron vulnerability and pathology (Nass & Blakely
2003, Nass et al. 2008). The nematode can easily be grown in microwell plates allowing for
medium throughput whole genome screens that can identify genes involved in a potential
phenotype. The C. elegans DA neurons contain the genes involved in DA signaling and
metabolism, and expression of fluorescent proteins in the neurons allows for the in vivo
analysis of neuronal morphology and integrity (Nass et al. 2002, Nass & Blakely 2003). The
nematode also contains strong orthologues to vertebrate MRPs and cell death genes, and the
DA neurons are sensitive to PD-associated toxicants including MeHg (Lakso et al. 2003,
Ved et al. 2005, Vanduyn et al. 2013, Vistbakka et al. 2012, Sheps et al. 2004, Nass et al.
2008, Settivari et al. 2009, Vanduyn et al. 2010). In this study we asked if there were
molecular transporters that may protect against MeHg-associated toxicity. Here we show
that a previously uncharacterized C. elegans MRP, MRP-7, inhibits MeHg-induced GST and
HSP gene expression and animal toxicity. We also show that the transporter modulates
whole animal Hg levels, is expressed in DA neurons, and inhibits MeHg-associated DA
neurodegeneration.
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Materials and Methods
C. elegans strains and maintenance
C. elegans strains were obtained from the Caenorhabditis elegans Genetics Center: Bristol
N2 wild-type (WT), NL2099 rrf-3(pk1426). The strain RJ928 was generated by a genetic
cross between BY250 (Pdat-1::GFP) and NL2099 (Settivari et al. 2009). Genetic crosses
were also performed between GFP reporter strains obtained from the CGC and NL2099 to
allow the observation of other neuronal types: GABAergic – EG1285 x NL2099
[Punc-47::GFP; rrf-3(pk1426)], glutamatergic – DA1240 x NL2099 [Peat-4::GFP;
rrf-3(pk1426)], cholinergic – LX929 x NL2099 [Punc-17::GFP; rrf-3(pk1426)], serotonergic
– GR1366 x NL2099 [Ptph-1::GFP; rrf-3(pk1426)]. Animals were cultured on NGM or 8P
plates with lawns of OP50 or NA22 bacteria, respectively, at 20°C according to standard
methods (Hope 1999, Brenner 1974).
RNAi reverse genetic screen
A RNAi screen in liquid was carried out using the Open Biosystems ORF RNAi feeding
library (10,953 genes) (Thermo Fisher Scientific, Waltham, MA, USA) and a sub-library
containing the clones from the Source BioScience (Ahringer) library (Nottingham, UK) that
are absent in the Open Biosystems library (7,555 genes). RNAi bacteria cultures were
prepared as described (Ahringer 2006). Approximately 40 synchronized L1 stage NL2099
worms were added to 50 μl of bacteria culture in a 96 well plate. The plates were incubated
in a shaker at 20°C for 2 days, MeHg was added to each well to a final concentration of 5
μM, and the worms were grown 2 more days in the presence of MeHg. Bacteria clones that
resulted in reduced viability in the liquid screen were confirmed with a live/dead assay on
agar plates as previously described (Vanduyn et al. 2010). NL2099 L1 stage worms were
grown on each RNAi clone for 48 h and assayed for viability following a 48 h exposure to
10 μM MeHg. Each clone was tested in triplicate (> 20 worms per replicate) and clones for
which the average percent live worms were significantly different from WT were identified.
RNAi clone sequencing
The RNAi feeding clone in well III-6J08 of the Source BioScience library was grown
overnight in LB broth + 50 μg/ml ampicillin and a miniprep kit was used to isolate plasmid
DNA (QIAprep Spin Miniprep Kit, Qiagen, Hilden, Germany). Sequencing services were
carried out by ACGT, Inc. (Wheeling, IL, USA) using their provided M13F (−20) primer.
The resulting nucleotide sequence was mapped to the C. elegans genome using the
BLASTN feature at WormBase.org.
Sequence alignment
A BLAST search of the C. elegans MRP-7 protein sequence revealed that 14 human
proteins match with an E value of 0.0, with identity scores ranging from 31–43%. MRP1
(ABCC1) shares 43% identity and 61% similarity with MRP-7, the highest of any of the
MRPs, so a sequence alignment was prepared between these proteins. The human MRP1
protein sequence (accession NP_004987.2) was obtained from the NCBI Protein database
and the C. elegans MRP-7 protein sequence was obtained from WormBase.org. ClustalW
was used to align the sequences. Fully conserved residues were highlighted in dark gray and
residues that are similar between the two sequences were highlighted in light gray (similar
includes both strongly and weakly similar residues as defined by ClustalW). The
transmembrane helices of MRP1 were indicated by a thick black line and the Walker A,
Walker B and the ABC signature sequences of MRP1 were indicated in boxes.
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Whole animal viability assay
RNAi by feeding was carried out on RNAi plates (NGM agar with 1 mM isopropyl β-d-
thiogalactoside (IPTG) and 100 μg/ml ampicillin) seeded with HT115(DE3) bacteria
(Kamath & Ahringer 2003). HT115 was transformed with the L4440 empty vector for a
control. To target mrp-7, the clone labeled C51G7.a located in well III-6J08 of the RNAi
feeding library from Source BioScience was used. Nematodes were exposed to RNAi for
two generations to ensure sufficient gene knockdown. For synchronization gravid adult
NL2099 strain nematodes were lysed with hypochlorite solution and the embryos were
incubated for 18 h in M9 buffer. L1 stage worms were washed three times in H2O and put
onto the RNAi plates. Worms (P0) were grown to adulthood and synchronized again. L1
larvae (F1) were placed on RNAi plates and grown for 24 h at 20°C (to the L2/L3 stage) and
then transferred to RNAi plates containing various concentrations of MeHg (CH3HgCl,
442534, Sigma-Aldrich, St. Louis, MO). After a 48 h incubation at 20°C, the number of live
worms was determined; worms were considered alive when a touch on the nose with a wire
pick caused movement. At least 20 worms were counted for each experiment and the
experiment was repeated 3 times. Results are presented as mean ± SEM.
RT-PCR analysis
NL2099 worms were exposed to MeHg under two different conditions before being
collected for RNA isolation. L1 stage worms were exposed to 400 nM MeHg for 4 days on
mrp-7 or empty vector RNAi bacteria (Novillo et al. 2005, Vanduyn et al. 2010). Second
generation mrp-7 RNAi or WT worms were grown to the L4 stage then exposed to 25 μM
MeHg for 4 h. After exposure, nematodes were washed from the plates with water and
TRIzol reagent (Life Technologies, Grand Island, NY, USA) was added to the pellet of
nematodes. Samples were frozen at −80°C and later thawed for processing, or RNA was
isolated immediately as previously described. The RNA was dissolved in nuclease-free H2O
and the concentration was measured using a ND-1000 spectrophotometer (Nanodrop
Technology, Wilmington, DE, USA). RNA samples were stored at −80°C. cDNA synthesis
was carried out using the Maxima First Strand cDNA Synthesis Kit for RT-qPCR (Thermo
Fisher Scientific, Waltham, MA, USA) following manufacturer’s instructions with 1 μg of
total RNA as the template. cDNA was quantified using a ND-1000 spectrophotometer and
stored at −20°C. RT-PCR primers were designed using Primer3 software to be gene specific
and exon spanning to avoid amplification of contaminating genomic DNA.
Glyceraldehyde-3-dehydrogenase (GAPDH) was selected as the gene for normalization in
the qRT-PCR because its expression does not change as a result of MeHg treatment
(Vanduyn et al. 2010). Primer sequences are listed in Supplementary Table 1. Real-time
PCR was performed using Maxima SYBR Green/ROX qPCR Master Mix (Thermo Fisher
Scientific, Waltham, MA, USA) and the StepOnePlus Real-Time PCR System (Life
Technologies, Grand Island, NY, USA). 25 μg of cDNA was used as the template, reactions
were performed in triplicate and each experiment was repeated with three independent
cDNA samples. Primer specificity and the formation of a single product were verified by a
melting curve. Relative fold change in expression of each gene was calculated using the
ΔΔCt method, normalized to GAPDH.
DA neurodegeneration assay
RNAi by feeding was carried out as described above using the strain RJ928. Gravid adult
RJ928 worms were lysed with hypochlorite solution and embryos were incubated for 18 h in
M9 buffer. L1 stage worms were washed three times in H2O and transferred onto RNAi
plates containing various concentrations of MeHg (0–0.5 μM) and control or mrp-7 RNAi
bacteria. Worms were incubated at 20°C for 4 days and then scored for DA neuron
degeneration as previously described (Vanduyn et al. 2010, Settivari et al. 2009). Briefly,
VanDuyn and Nass Page 4
J Neurochem. Author manuscript; available in PMC 2015 March 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
50–60 worms were immobilized on a 2% agarose pad with 2% sodium azide and the GFP-
expressing DA neurons were observed using a fluorescent microscope (Leica MZ 16 FA,
Leica Microsystems, Heerbrugg, Switzerland). To illustrate the degeneration, a Z-stack of
images was captured using the FV1000-MPE Confocal/Multiphoton Microscope (Olympus
America, Center Valley, PA, USA) and the Max Intensity Z projection image was created in
ImageJ (Rasband 1997–2012). The results are presented as the percent of worms with
normal CEPs. The experiment was repeated at least 3 times and bars represent the mean ±
SEM.
Sample preparation for Hg level determination
NL2099 worms grown on RNAi plates seeded with the appropriate RNAi bacteria to the
gravid adult stage (P0) were lysed with hypochlorite solution, embryos were incubated in
M9 solution for 18 h, and synchronized L1s (F1) were placed onto RNAi plates. Worms
were grown for 3 days to the adult stage then transferred to RNAi plates containing 1 μM
MeHg and seeded with the appropriate RNAi bacteria. Worms were grown on the RNAi +
MeHg plates for the indicated amount of time at 20°C. After exposure, worms were
collected in pre-weighed metal-free 1.5 ml tubes and the worm pellets were washed three
times with ice cold H2O. Since L1s were present on the plate, the adult worms were allowed
to settle by gravity on ice and the L1s were removed during the washes to ensure that the Hg
measurement reflected only the content in adult worms. After the final wash, the H2O was
removed and samples were frozen at −20°C until further processing. Frozen worm pellets
were thawed, excess H2O was removed, and the weight was recorded. Samples were
transferred into Teflon vessels with 50% HNO3 and digested using the MARSXpress
microwave digestion system (CEM, Matthews, NC, USA).
ICP-MS analysis
The digested worm samples were diluted with H2O to 2% acid. Samples for introduction
into the instrument included the worm sample diluted to 0.1 mg/ml based on the wet weight
of the original pellet, an internal standard mixture containing Bi, In, Li, Sc, Tb, Y (IV-
ICPMS-71D, Inorganic Ventures, Christiansburg, VA, USA) at 1 ppb, and Au
(MSAU-10PPM, Inorganic Ventures, Christiansburg, VA, USA) at 200 ppb. Samples were
introduced into the X Series ICP-MS (Thermo Fisher Scientific, Waltham, MA, USA)
and 202Hg was monitored with Y and Bi as the internal standards. The [Hg] in ng/ml (ppb)
was divided by the concentration of worms in the sample and the data was expressed as ng
Hg/mg worms (wet weight) or ppm Hg. Four samples were collected for each strain at each
time point and bars represent the mean ± SEM.
Plasmid construction and generation of transgenic animals
For co-expression studies, CFP and YFP were used as these fluorophores have minimal
overlap in their excitation and emission spectra and are frequently used together for double-
labeling experiments (Miller et al. 1999). To express YFP in the DA neurons, the GFP in
pRN200 (Nass et al. 2002) was replaced with YFP from the vector L4817 (Fire Lab Vector
Kit, Addgene, Cambridge, MA, USA). pRN200 and L4817 were digested with AgeI and
ApaI which flank the GFP or YFP regions of the plasmids. The YFP fragment was ligated
into the pRN200 vector using ExpressLink T4 DNA Ligase (Invitrogen, Carlsbad, CA,
USA) and the construct was confirmed with PCR. A transcriptional fusion for mrp-7 was
created by amplifying a 3466 bp region 5′ of the start codon from genomic DNA based on
primers designed by The Genome BC C. elegans Gene Expression Consortium (Hunt-
Newbury et al. 2007): F –
GTCGACTAGAGGATCCTTTAAAATCTCGTCGACATCACT, R–
CCAATCCCGGGGATCCCTAATTTTTGGAGTTTGTGTT. The In-Fusion HD cloning
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system (Clontech, Mountain View, CA, USA) was used to insert the putative mrp-7
promoter into a vector created by replacing the GFP in pPD95.73 with CFP from L4816 (as
described above) and linearized with BamHI. Transgenic animals expressing the
transcriptional fusion were generated by injecting N2 worms with Pmrp-7::CFP at 75 ng/μl,
Pdat-1::YFP at 50 ng/μl, pRF4 [rol-6(su1006)] at 50 ng/μl and pUC19 at 25 ng/μl.
Transgenic animals were identified by the roller phenotype.
Confocal microscopy analysis
Primary cell cultures were created using embryos from the new Pmrp-7::CFP strain (RJ1089)
as previously described (Bianchi & Driscoll 2006, Vanduyn et al. 2010). Worm cultures
were started by picking rollers to enrich for transgenic animals and grown to the gravid adult
stage. Hypochlorite synchronization solution was added to lyse the adults and the eggs were
collected and washed with egg buffer (118 mM NaCl, 48 mM KCl, 2 mM CaCl2, 2 mM
MgCl2, 25 mM HEPES). Sucrose flotation (60%) was used to separate the eggs from debris,
and chitinase (C6137, Sigma, St. Louis, MO, USA) was used to digest the eggshells. The
embryonic cells were dissociated using a syringe and a 21-gauge needle. Cells were grown
in L-15 medium (containing 10% FBS and 1% pen/strep), on polylysine-coated cover slips
at 20°C. After a 72 h incubation, cells were fixed with 4% paraformaldehyde and mounted
onto slides with VECTASHIELD HardSet Mounting Medium (Vector Laboratories,
Burlingame, CA, USA). Confocal images were obtained using the Nikon Eclipse Ti with
NIS Elements AR software (Nikon Instruments Inc., Melville, NY, USA) and 440 nm and
514 nm lasers. Z-stacks were created in ImageJ.
Statistics
All results are presented as mean ± SEM. Statistical analysis was carried out using
GraphPad Prism software (GraphPad Software, San Diego, CA, USA). A student’s t-test
was used to analyze the difference between two groups. One-way ANOVA with a
Bonferroni post-hoc test was performed to compare the expression levels of each gene as
measured by RT-PCR between the different exposure conditions. Two-way ANOVA with a
Bonferroni post-hoc test was performed to compare WT and RNAi animals under different
exposure conditions.
RESULTS
The putative multidrug resistance transporter MRP-7 inhibits MeHg-induced animal death
MeHg is a potent environmental neurotoxicant that has been associated with disruption of
microtubule integrity, neuronal axon guidance, and cell death (Guo et al. 2013, Sager &
Syversen 1984, Ceccatelli et al. 2010). The genetic pathways and mediators of the MeHg-
induced defects are largely ill-defined. In order to identify genes whose expression inhibits
MeHg-associated toxicity, we utilized RNAi to knock down gene expression of over 90% of
the genes in the C. elegans genome, and identified a gene designated by the primer pair
G51G7.a from the Ahringer RNAi library whose genetic repression dramatically increases
MeHg-associated animal sensitivity. Sequencing of the designated gene fragment indicated
the gene is not wah-1 as annotated in the Ahringer library, but the gene Y43F8C.12, which
codes for the putative multidrug resistance protein MRP-7. A BLAST search with the
human genome and a sequence alignment using ClustalW2 suggest that this previously
uncharacterized protein is most homologous to the human MRP1 protein (Fig. 1). The C.
elegans MRP-7 protein is highly conserved with human MRP1 (61% similarity and 43%
amino acid identity). The putative transporter is predicted to have 3 transmembrane domains
(TMDs) and, consistent with vertebrates, 17 transmembrane helices, Walker A, ABC
signature, and Walker B consensus sequences between TMD 11 and TMD 12, and within
the C-terminus (Bakos et al. 1996, Frelet & Klein 2006).
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Our previous studies in C. elegans indicate that MeHg confers concentration-dependent
animal death with an LC50 of 95 μM (Vanduyn et al. 2010). Vertebrate MRPs have been
shown to confer increased resistance to toxic substrates in a dose-dependent manner, largely
by pumping substances out of the cell (Leslie et al. 2004). In order to determine if a
reduction in MRP-7 would significantly reduce the LC50, nematodes were first grown on
RNAi bacteria to reduce expression of mrp-7; the reduction in mRNA levels of mrp-7 was
confirmed by quantitative RT-PCR (Supplementary Fig. 1). Animals were then exposed to
various concentrations of MeHg ranging from 0–10 μM, and the number of live animals was
determined 48 h later. We find that a decrease in mrp-7 gene expression results in a dramatic
reduction in the LC50 to approximately 5 μM (Fig. 2). Furthermore we utilized RNAi to
evaluate whether any of the other MRPs may contribute to MeHg-associated vulnerability,
and found that no other gene affected animal viability (data not shown). These results
indicate that MRP-7 inhibits MeHg-induced animal death in a dose dependent manner, and
suggests that the protein may inhibit toxicity through limiting Hg accumulation within the
cell.
MRP-7 expression reduces whole-animal Hg levels
Expression of MRP1 confers resistance to a variety of toxicants, and has been shown to
actively transport metalloids as well as glutathione (GSH) and GSH-conjugated xenobiotics
(Dallas et al. 2006). In vertebrates MeHg has been shown to induce the expression of
glutathione S-transferases (GSTs) that conjugate the toxicant to GSH allowing for cellular
excretion through phase III proteins. Considering the high homology between MRP1 and
MRP-7, and that MRP1 has been shown to play a role in phase III detoxification, we asked
whether MRP-7 could be involved in limiting cellular Hg levels. To determine if MRP-7
expression can modulate whole animal Hg levels, we grew WT or mrp-7 RNAi adult
animals on 1 μM MeHg for up to 48 h and determined whole animal Hg concentrations by
ICP-MS. We find that mrp-7 RNAi animals have approximately 2-fold greater levels of Hg
than WT at the later time points of chronic MeHg exposure (Fig. 3). These results indicate
that MRP-7 may transport Hg out of the cell to reduce MeHg-associated cellular stress.
MRP-7 expression reduces MeHg-associated endoplasmic reticulum, mitochondria, and
Golgi apparatus stress response
Exposure to MeHg has been shown to increase cellular ROS and stress response gene
expression in both vertebrates and in nematodes (Yu et al. 2010, Limke et al. 2004, InSug et
al. 1997, Goering et al. 2000, Vanduyn et al. 2010, Rudgalvyte et al. 2013). In order to
determine if the expression of MRP-7 may modulate MeHg-associated cellular stress,
particularly in specific intracellular compartments, we evaluated gene expression levels of
several glutathione S-transferases (GSTs) and heat shock proteins (HSPs) following both
acute and chronic toxicant exposures in both WT and mrp-7 genetic knockdown animals.
GST-38 is expressed within the intestines and nervous system and has been shown to affect
whole animal vulnerability to numerous toxicants and other stressors, including MeHg
(Vanduyn et al. 2010, Liao & Freedman 1998). HSP-6 and HSP-16.1 are expressed
exclusively in the mitochondria and Golgi apparatus, respectively, with the latter involved in
maintaining Ca2+ homeostasis in the Gogi by functionally interacting with the Ca2+ and
Mn2+ transporter PMR-1 (Kourtis et al. 2012). HSP-4 is a member of the hsp70 family of
molecular chaperones that has been shown to be upregulated in response to ER stress (Ient et
al. 2012). A 4-hr exposure to MeHg results in over 30-fold increase in gst-38 and hsp-16.1
gene expression, suggesting as in vertebrate studies that the toxicant perturbs redox
homeostasis, protein folding, and Ca2+ regulation (Fig. 4a and b) (Kourtis et al. 2012, Lee &
Lee 2013). We do not find a significant change in gene expression of either of these proteins
(or the other tested stress response proteins) in a mrp-7 genetic knockdown background
compared to WT following acute exposure, consistent with lower cellular Hg levels found in
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both genetic backgrounds (Fig. 3). In contrast, following a chronic 96-hr exposure to MeHg,
there is a significant increase in hsp-4, hsp-6, and hsp-16.1 gene expression in mrp-7 RNAi
animals relative to WT animals, suggesting that an increase in cellular Hg levels disrupts
protein homeostasis or function within the endoplasmic reticulum, mitochondria, and Golgi
complex, respectively (Fig. 4d) (Kourtis et al. 2012, Ient et al. 2012, Lee & Lee 2013). We
have also recently shown that the PD-associated GST-π homologue GST-1 in C. elegans is
expressed in DA neuron and modulates toxicant-induced DA neurodegeneration (Settivari et
al. 2013). MRP-7 RNAi animals chronically exposed to MeHg show a small but significant
increase in gst-1 expression (Fig. 4c) suggesting that cells that express gst-1 are also
sensitive to MeHg. These results suggest that MRP-7 may also be expressed in DA neurons
and play a role in modulating MeHg-associated DA neuron vulnerability.
Chronic MeHg exposure induces MRP-7 gene expression
Cellular resistance to hormones, xenobiotics, and heavy metals has been correlated with an
increase in MRP expression (Deeley & Cole 2006, Magnarin et al. 2004, James & Davey
2009). Inorganic Hg has been shown to induce MRPs in mammalian and fish cell lines that
results in increases in toxicant efflux and cellular resistance (Della Torre et al. 2012, Aleo et
al. 2005). We have shown that genetic knockdown of mrp-7 results in an increase in the
cellular stress response and whole animal sensitivity to MeHg indicating that MRP-7 plays
an integral role in reducing cellular toxicity and suggests that as in vertebrates, MRP-7
expression may be induced to facilitate cellular excretion of the toxicant (Fig. 2 and 4). In
order to determine if MRP-7 gene expression may be modulated by chronic exposure to
MeHg, we utilized RT-PCR to evaluate mrp-7 gene expression levels in control and animals
exposed to 400 nM MeHg for 96 h. As can be seen in Fig. 5, the exposure group has an
approximately 1.7-fold increase mrp-7 mRNA levels relative to unexposed animals. We find
no change in mrp-7 expression levels in acute exposure conditions, consistent with the
relatively low level of MeHg-associated stress (data not shown). These results indicate that
MeHg induces mrp-7 gene expression following chronic exposures to the toxicant and
suggests that a concomitant increase MRP-7 protein may contribute to the cellular
resistance.
MRP-7 is expressed in DA neurons
Vertebrate studies have shown that MeHg confers DA neuronal dysfunction and cell death
(Gotz et al. 2002, Tiernan et al. 2013). Our prior studies have demonstrated that low chronic
exposure to MeHg also confers DA neurodegeneration in C. elegans (Vanduyn et al. 2010).
Considering that MRP-7 inhibits MeHg-associated animal toxicity and Hg accumulation, we
asked whether MRP-7 is expressed in DA neurons which could facilitate cellular Hg efflux.
To determine if MRP-7 may be expressed in C. elegans DA neurons, we first generated
transgenic animals (RJ1089) co-expressing yellow fluorescent protein (YFP) behind the
endogenous dopamine transporter (DAT-1) promoter and cyan fluorescent protein (CFP)
behind the endogenous MRP-7 promoter (Fig. 6a–d) (Hunt-Newbury et al. 2007, Nass et al.
2002). In vivo analysis of the expression pattern of the MRP-7 reporter fusion indicates that
the protein is expressed in head neurons (as well as several other cells in the body), but the
expression pattern within the head made it difficult to determine whether the protein is
specifically expressed in the DA neurons (Fig. 6a–d). We therefore generated primary
cultures from the RJ1089 animals, and observed MRP-7-associated CFP fluorescence in all
cells expressing YFP, indicating that the approximately 3.5 kb promoter of MRP-7 is
sufficient to drive the expression of the MRP protein in DA neurons (Fig. 6e–h). The
expression of MRP-7 in other cell types is also consistent with the differential expression
patterns of MRP1 in vertebrates (Dallas et al. 2006). These results indicate that MRP-7 is
likely expressed in DA neurons and suggests that the transporter may inhibit MeHg-
associated DA neurodegeneration.
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MRP-7 inhibits MeHg-induced DA neurodegeneration in vivo
MRPs inhibit cellular toxicity by transporting substrates out of the cell. Considering that
MRP-7 inhibits MeHg-associated animal toxicity and the MRP-7 transcriptional fusion
suggests the transporter is expressed in DA neurons, we asked if MRP-7 expression may
inhibit MeHg-associated DA neurodegeneration. L1 animals were grown on plates
containing various concentrations of MeHg and seeded with RNAi bacteria targeting mrp-7
or containing an empty vector. After 4 days, the DA neurons were evaluated under a
fluorescent dissecting microscope. Chronic exposure of mrp-7 RNAi animals to 400 nM
MeHg results in approximately 60% of the animals displaying significant DA
neurodegeneration, while none of the WT animals show DA neuronal death (Fig. 7c and e).
Importantly, there does not appear to be any gross morphological differences, or differences
in growth and development between WT and mrp-7 RNAi animals for this exposure
condition, suggesting that the toxicant is not causing large scale cell death (Fig. 7a–d). Also,
we did not see any morphological changes in neurons in WT or mrp-7 knockdown animals
expressing a GFP reporter in serotonergic, cholinergic, glutamatergic, or GABAergic
neurons following toxicant exposure or any other apparent change (data not shown),
suggesting that mrp-7 does not play a role in affecting MeHg-associated vulnerability within
these cells. Also, considering that vertebrate MRPs can have broad substrate specificities
(Deeley & Cole 2006), and we have shown that the nematode’s DA neurons are vulnerable
to the PD-associated toxicants Mn2+ and Al3+ (Settivari et al. 2013, Vanduyn et al. 2013),
we evaluated if MRP-7 may play a role DA neuron vulnerability to these metals. Our
preliminary studies do not show a difference in whole animal or DA neuron vulnerability in
WT and mrp-7 genetic knockdown animals (data not shown), suggesting that MRP-7 is not
involved Mn2+- or Al3+-associated toxicity, although other MRPs could theoretically
compensate for the loss of the transporter. Overall these studies indicate that MRP-7 is
expressed in DA neurons, and MRP-7 expression is sufficient to inhibit MeHg-induced DA
neurodegeneration.
DISCUSSION
MeHg is a potent environmental neurotoxicant for which exposures can result in motor and
sensory deficits, mental retardation and death (Clarkson & Magos 2006). Exposures to
MeHg may also be a contributing factor in the development of PD, a neurological disorder
resulting in the loss of DA neurons in the substantia nigra (Petersen et al. 2008). When
exposed to MeHg, C. elegans recapitulates fundamental hallmarks of toxicant-associated
animal pathology and neurodegeneration, yet as in its vertebrate counterparts, the molecular
pathways and transporters involved in the cell death are ill-defined (Vanduyn et al. 2010). In
this study we incorporated an unbiased, whole genome reverse genetic screen to identify
genes for which expression inhibits MeHg-associated toxicity. Here we show that the
putative ABC transporter MRP-7 is expressed in the DA neurons and inhibits MeHg-
associated DA neurodegeneration. This study shows for the first time that an MRP is
expressed in vivo in DA neurons, and suggests that the transporter may help mediate
environment-associated neuropathology.
MRPs play an integral role in transporting xenobiotics out of non-neuronal cells and are a
major contributor to multidrug resistance in cancer, but remarkably few studies have
targeted MRPs to specific neuronal types or associated neuronal expression with function
(Dallas et al. 2006). Although numerous vertebrate MRPs have been identified in the CNS,
most notably within the blood-brain and blood-cerebrospinal barriers, microglia, and
astrocytes, studies of MRP expression and function in the brain have often yielded
contradictory results (Dallas et al. 2006). Mrp1, Mrp3, Mrp4, and Mrp5 transcripts have
been identified in primary cultures of embryonic rat brain neurons and oligodendrocytes,
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and immunohistochemical studies in human brain sections suggest expression of MRP4,
MRP5, and MRP8, but neuron-specific expression and functional studies are lacking
(Hirrlinger et al. 2002, Nies et al. 2004, Bortfeld et al. 2006). The relatively high number of
isoforms (9) and overlapping specificities and tissue expressions, both in normal and
pathological states, have likely contributed to the experimental discrepancies and inhibited
more mechanistic studies (Dallas et al. 2006).
Several recent studies have implicated vertebrate MRP2 in modulating inorganic Hg levels
in the GI tract and kidney and possibly in other cell types. MRP2 expression in liver and
kidney has been shown to eliminate Hg from the organs, likely through Cys-S-conjugates
with glutathione (GSH) (Bridges et al. 2011). MeHg may also be oxidized to inorganic Hg
and excreted similarly (Norseth & Clarkson 1970). Furthermore, MRP2 may reduce fetal
and placental burden of MeHg by transport through the placenta (Bridges et al. 2012).
Recently Lobner and colleagues reported that GSH supplementation protects mixed cortical
cultures containing neurons and glia from MeHg-associated cytotoxicity (Rush et al. 2012).
Co-exposure with the organic anion transporter and MRP inhibitor MK571 increased
cellular Hg levels and toxicity, suggesting that an MRP isoform that is sensitive to MK571
(MRP1, MRP2, MRP4, or MRP5) may play a role in Hg efflux (Rush et al. 2012, Lania-
Pietrzak et al. 2005, Pratt et al. 2005, Reid et al. 2003, Yamazaki et al. 2005). Our studies
show MeHg induces MRP-7 gene expression, consistent with vertebrate studies that show
MRPs can be induced by inorganic Hg and MeHg (Toyama et al. 2007, Della Torre et al.
2012, Liu et al. 2003). We also show that acute and chronic MeHg exposure results in a
large induction of gst-38 gene expression (approximately 4- to 35-fold) suggesting that
GST-38 responds immediately and during long-term exposure and may be involved in
reducing cellular Hg levels through conjugating GSH to MeHg (or Hg) to facilitate MRP-7-
associated cellular export.
This study also provides insight into the intracellular HSP stress response involved in
MRP-7-associated inhibition of MeHg toxicity. Acute exposure of animals (with or without
MRP-7 expression) to MeHg results in a dramatic increase in hsp-16.1 gene expression
suggesting that Golgi-associated Ca2+ regulation is particularly vulnerable to MeHg-
associated toxicity. These results are consistent with vertebrate studies that show that
cellular toxicity involves disruption of intracellular Ca2+ homeostasis (Atchison & Hare
1994). The induction of the ER-associated hsp-4 and mitochondria-associated hsp-6 in the
mrp-7 RNAi background when the intracellular Hg levels are high (ie, chronic exposure)
suggests that MRP-7 expression limits MeHg-associated ER and mitochondria toxicity.
These results are also consistent with vertebrate and our recent nematode studies that show
that MeHg confers mitochondria deficits and ER stress (Rudgalvyte et al. 2013, Vanduyn et
al. 2010).
It is intriguing to consider that MeHg-associated MRP expression or function could play a
role in the development and/or progression of PD. At least three theoretical possibilities for
the increased loss of DA neurons in PD have been proposed: 1) a genetic or in utero event or
exposure results in a decrease in DA neurons at birth followed by a normal rate of neuronal
loss due to aging; 2) an environmental insult sometime after birth decreases the number of
DA neurons followed by normal aging-related rate of decline; 3) an unknown factor
increases the rate of DA neuronal death or vulnerability during the lifespan (Langston 1990).
Low chronic exposure to MeHg in humans results in neurological and behavioral effects that
may not manifest for many years after exposure (Yorifuji et al. 2011) It is possible that
MeHg exposure in utero or postnatally may result in DA neuronal loss and/or increase DA
neuron vulnerability to environmental neurotoxicants. Our DA neurodegeneration studies
are in line with the last two theoretical possibilities on DA neuronal loss in PD, as animals
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that are exposed to low chronic levels of MeHg soon after hatching and into early adulthood
show DA neuron degeneration.
A limited availability of GSH to interact physically or functionally with MRP may increase
DA neuron vulnerability. PD patients often have a 40–50% reduction in GSH within the
substantia nigra the neurons often show significant hallmarks of oxidative stress (Zeevalk et
al. 2008). Chronic exposure to MeHg through food sources such as fish may also reduce
GSH levels, as vertebrate studies have shown that the toxicant can inhibit intracellular GSH
accumulation (Yee & Choi 1996, Franco et al. 2009, Amonpatumrat et al. 2008). If
conjugation of MeHg or Hg to GSH is necessary for MRP to transport the toxicant out of the
cell, a MeHg-associated reduction in GSH could inhibit Hg efflux through MRP
exacerbating DA neurodegeneration in normal and (pre-clinical) PD patients.
Although there have been no published reports of MRPs associated with the development of
PD, polymorphisms in another class of membrane transporters involved in cellular efflux of
toxicants, MDR1/ABCB1, have been associated with the disease. In a study of Chinese PD
patients, three SNPs in MDR1 were significantly associated with the risk for PD in males
over age 60 (Lee et al. 2004). Also individuals who had a history of pesticide exposure and
had at least one mutant isoform of MDR1 had a 5-fold increased risk of the disease
compared to the non-exposed patients (Drozdzik et al. 2003). The correlation between an
MDR1 polymorphism, pesticide exposure, and PD was also found to be significant in a
study of French patients (Dutheil et al. 2010). These studies suggest that phase III proteins
may play a role inhibiting DA neuron vulnerability in PD.
In summary our findings show that a putative MRP, MRP-7, inhibits MeHg-associated DA
neurodegeneration. We also show that the transporter plays a role in efflux of Hg from the
cell and is expressed in the DA neurons. These studies indicate that MRP expression or
function may significantly affect DA neuron vulnerability to both endogenous and
exogenous xenobiotics, and suggest a novel therapeutic target to inhibit PD-associated
pathologies.
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Figure 1.
Sequence alignment of human MRP1 with C. elegans MRP-7. ClustalW was used to align
human MRP1 (accession NP_004987.2) with C. elegans MRP-7 (accession NP_507812.3).
Identical residues are highlighted in dark gray and similar residues are highlighted in light
gray. Thick black lines indicate the transmembrane domains of MRP1 and the conserved
Walker A, Walker B and ABC signature sequences are boxed.
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Figure 2.
MRP-7 inhibits MeHg-induced whole animal death. RNAi sensitive NL2099 worms were
grown on RNAi bacteria to knock down mrp-7 expression or empty vector for WT control
and second generation L3 animals were exposed to the indicated concentrations of MeHg for
48 h. The number of live worms was counted and indicated as the percent of the total
number of worms (> 50 per condition). The data is presented as mean ± SEM of 4
independent replicates. Data was analyzed by two-way ANOVA with Bonferroni post-tests.
mrp-7 RNAi is significantly different from WT with p < 0.05 (#) or p < 0.001 (*).
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Figure 3.
MRP-7 inhibits the accumulation of MeHg. RNAi sensitive NL2099 worms were grown on
RNAi bacteria knocking down mrp-7 expression or empty vector for WT control and second
generation adult animals were exposed to 1 μM MeHg for the indicated amount of time.
Following exposure, worms were collected and the Hg content was measured by ICP-MS.
Hg content was normalized to the wet weight of the worm samples and the data is presented
as mean ± SEM of 4 independent replicates. Data was analyzed by two-way ANOVA with
Bonferroni post-tests. mrp-7 RNAi is significantly different from WT with p < 0.001 (*).
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Figure 4.
GST and HSP mRNA expression are increased following MeHg exposure. Animals were
exposed to 25 μM MeHg for 4 hours (a and b) or 400 nM MeHg for 4 days (b and d) and
mRNA expression was measured by RT-PCR and analyzed using the ddCt method with
normalization to GAPDH. dCt values for each gene were analyzed by one-way ANOVA
followed by a Bonferroni post-test, * indicates a significant difference from the control
treated group at p < 0.001 (a), p < 0.01 (b and d) or p < 0.05 (c), # indicates a significant
difference between the WT and mrp-7 RNAi MeHg treated groups at p < 0.05.
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Figure 5.
mrp-7 mRNA levels are increased following chronic MeHg exposure. NL2099 L1 stage
worms were grown on 400 nM MeHg for 4 days and mrp-7 mRNA expression was
measured by RT-PCR and analyzed using the ddCt method with normalization to GAPDH.
dCt values for control and MeHg groups were compared using a student’s t-test. * indicates
a significant difference, p < 0.05.
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Figure 6.
MRP-7 is expressed in C. elegans DA neurons. Confocal imaging was used to visualize the
expression of YFP and CFP in RJ1089 [Pdat-1::YFP; Pmrp-7::CFP] young adult nematodes
(a–d) and primary cultures (e–f). DA neurons were identified by the presence of YFP (b and
f). MRP-7 expression (c and g) was detected in the DA neurons as well as other cells (d and
h), but not all cells (a and e).
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Figure 7.
MRP-7 inhibits MeHg-associated DA neuron degeneration. RNAi sensitive RJ928 L1 stage
worms were grown on plates containing MeHg and seeded with RNAi bacteria targeting
mrp-7 or empty vector. After 4 days, the DA neurons were visualized using a fluorescent
microscope and scored for degeneration. Worms are considered normal if all 4 CEP
processes are intact from the cell body to the tip of the nose. MeHg (0.5 μM) does not affect
the DA neurons in WT animals (a) however exposure to 0.5 μM MeHg causes degeneration
of the DA neurons in the absence of mrp-7 (c). The DIC images (b, d) illustrate that there
are no gross morphological differences between WT and mrp-7 RNAi, and the animals are
of similar size (scale bar is 50 μM). Quantification of degeneration is presented as the
percent of worms with normal CEPs (e). The data is presented as mean ± SEM of 5
independent replicates. Data was analyzed by two-way ANOVA with Bonferroni post-tests.
mrp-7 RNAi is significantly different from WT with p < 0.01 (#) or p < 0.001 (*).
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